Search clinical trials for: Hypertension, Aliskiren, Amlodipine

Total 647 results

University of Erlangen-Nürnberg Medical School
Chiesi Farmaceutici S.p.A.

Completed

A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive Patients

Hypertension

Germany
Sanofi

Completed

Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy

Hypertension

Russian Federation
Seoul National University Hospital
Dong-A Pharmaceutical Co., Ltd.

Completed

Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon

Raynaud Phenomenon

Korea, Republic of
Novartis

Completed

Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus (ViVID)

Hypertension

United States
Creighton University

Completed

Black Education and Treatment of Hypertension (BEAT HTN) (BEAT)

Hypertension

United States
Novartis Pharmaceuticals
Baker Heart and Diabetes Institute

Completed

Valsartan Intensified Primary Care Reduction of Blood Pressure Study (VIPER-BP)

Hypertension

United States, Australia
Gulhane School of Medicine

Completed

Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria Purpose

We Searched for the Effects of Calcium Channel Blocker Amlodipine on the Clinical and Laboratory Parameters of Diabetic Patients With Proteinuria.

Turkey
Chong Kun Dang Pharmaceutical

Completed

CKD-828 S-Amlodipine Non-Responder Trial

Hypertension

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

CKD-828 Telmisartan Non-Responder Trial

Hypertension

Korea, Republic of
Novartis Pharmaceuticals

Completed

A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction Between Aliskiren and Furosemide in Patients With Heart Failure

Heart Failure

Germany, Lithuania
University of Leeds
The Leeds Teaching Hospitals NHS Trust

Completed

Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression

Hypertension | Left Ventricular Hypertrophy

United Kingdom
RenJi Hospital

Unknown

Blood Pressure Variability and the Prognosis of Ischemic Stroke With Intracranial Artery Stenosis

Intracranial Artery Stenosis | Blood Pressure Variability

China
Chinese Academy of Medical Sciences, Fuwai Hospital

Unknown

Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients (CHIEF)

Essential Hypertension

China
Biomedis International Ltd.

Unknown

Recurrent Stroke Prevention Clinical Outcome Study (RESPECTS)

Stroke | Hypertension | Blood Pressure

Japan
Korea Otsuka Pharmaceutical Co., Ltd.

Completed

Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina (STELLA)

Variant Angina

Korea, Republic of
University of Campania "Luigi Vanvitelli"
IRCCS San Raffaele

Unknown

Aliskiren or Amlodipine in Hypertensive Hemodialysed Patients

Hypertension | Dialysis

Italy
University of Western Ontario, Canada
Pfizer

Completed

STITCH2 (Simplified Therapeutic Intervention to Control Hypertension and Hypercholesterolemia) (STITCH2)

Hypertension | Hypercholesterolemia

Canada
Novartis

Completed

Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension

Essential Hypertension

Japan
Ruttonjee Hospital

Completed

Effect of Amlodipine on Anti-platelet Drug Effect in Patients With Coronary Artery Disease

Ischemic Heart Disease

China
Novartis

Completed

Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients (EXAM)

Hypertension

China
HK inno.N Corporation

Completed

Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mg

Healthy

Korea, Republic of
Novartis

Completed

Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension (AACESS)

Hypertension

United States
Novartis Pharmaceuticals

Completed

The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction

Hypertension | Diastolic Dysfunction

United States
Aarhus University Hospital
University of Aarhus

Completed

Intensive Vasodilator Therapy in Patients With Essential Hypertension (Vasomore)

Essential Hypertension | High Blood Pressure

Denmark
The Louis & Rachel Rudin Foundation
Daiichi Sankyo, Inc.

Completed

Renin Profiling in Selection of Initial Antihypertensive Drug

Hypertension

United States
Gateshead Health NHS Foundation Trust
Newcastle-upon-Tyne Hospitals NHS Trust; National Institute for Health Research...

Unknown

Vascular Augmentation of Late-life Unremitted Depression (VALUeD) (VALUeD)

Depression

United Kingdom
Hospital Universitario Pedro Ernesto
Novartis

Withdrawn

Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan

Hypertension | Diabetes Mellitus

Brazil
Bayer

Completed

Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension

Hypertension

Japan
Daiichi Sankyo, Inc.

Completed

Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

Hypertension

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions

Fed

India
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions

Fasting

India
Novartis Pharmaceuticals

Terminated

Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension

Hypertension | Ankle Edema

Netherlands
Charite University, Berlin, Germany
German Research Foundation

Completed

Evaluation of Three Continuation Therapies After ECT Concerning Efficacy and Cognition in Severly Depressed Patients (EffECT)

Depression | Major Depression

Germany
Novartis

Completed

A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine

Hypertension

Switzerland, Germany
Novartis

Completed

To Find Out Whether Valsartan With or Without Other Blood Pressure Medications Would Improve the Ability of the Heart to Fill and Empty, and the Ability of the Heart Muscle to Relax Adequately in People With High Blood Pressure.

Hypertension | Diastolic Dysfunction

United States
Novartis

Completed

8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension

Hypertension

United States
Novartis

Completed

One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension

Hypertension

United States, Germany
Novartis

Completed

Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.

Hypertension

Switzerland
Novartis

Completed

Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension

Hypertension

Switzerland
Novartis

Completed

Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus

Hypertension

United States
Novartis

Completed

Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome

Hypertension | Metabolic Syndrome
Novartis

Completed

Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients

Hypertension

United States, Germany
Novartis

Completed

A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine

Hypertension

Germany, United States
Novartis Pharmaceuticals

Completed

Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension

Hypertension

United States
Novartis

Completed

Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension

Hypertension

United States
Hospital de Clinicas de Porto Alegre
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil; Conselho...

Unknown

Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy

Diabetes Mellitus | Arterial Hypertension

Brazil
Novartis

Completed

To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone

Hypertension | High Blood Pressure

Taiwan
Novartis

Completed

Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension (ACCELERATE)

Hypertension

Switzerland, United Kingdom, Venezuela, France, South Africa, Greece, Canada, Costa Rica, Germany, Guatemala
Chong Kun Dang Pharmaceutical
Asan Medical Center

Completed

CKD-828 Drug Interaction Study (Telmisartan)

Healthy Male Volunteers

Korea, Republic of
Chong Kun Dang Pharmaceutical
Asan Medical Center

Completed

CKD-828 Drug Interaction Study (S-amlodipine)

Healthy Male Volunteers

Korea, Republic of

3

Subscribe